ARTICLE | Finance
Plus: New fundings for Exsilio, TwoStep and Augustine
By Paul Bonanos, Director of Biopharma Intelligence
June 28, 2024 12:33 AM UTC
Two-year-old investor and accelerator Curie.Bio has raised $380 million to continue building young biotechs, with a goal of preserving equity for founders as they advance high-potential programs.
Established in 2022 by Flatiron Health Inc. co-founder Zach Weinberg and former Third Rock Ventures partners Christoph Lengauer and Alexis Borisy, Curie.Bio has thus far backed 20 start-ups. The firm supplies operational support and drug-hunting assistance to founders, investing small amounts in the nascent projects…
- SEO Powered Content & PR Distribution. Get Amplified Today.
- PlatoData.Network Vertical Generative Ai. Empower Yourself. Access Here.
- PlatoAiStream. Web3 Intelligence. Knowledge Amplified. Access Here.
- PlatoESG. Carbon, CleanTech, Energy, Environment, Solar, Waste Management. Access Here.
- PlatoHealth. Biotech and Clinical Trials Intelligence. Access Here.
- Source: https://www.biocentury.com/article/652829/venture-report-curie-bio-s-fund-megarounds-for-formation-evolutionaryscale-billiontoone